Chair of the Novo Nordisk Board Helge Lund thinks tax payers will be paying a large bill for the Covid-19 crisis. He also expects an additional pressure to fall on the pharmaceutical industry in future years.
Denmark wishes to establish a Covid-19 research fund with Israel and Austria and explore the possibility of a joint vaccine production with the two countries, according to the parties at a press conference.
Even though Eli Lilly presented strong data in a comparison study between this company's drug tirzepatide and Novo Nordisk's rival semaglutide, it'll take more to eliminate the Danish competition, according to an analyst.
Danish PM Mette Frederiksen declares interest in the idea of Denmark establishing vaccine factories in collaboration with Israel just before traveling to this country, where she will discuss vaccine infrastructure with Israeli PM Benjamin Netanyahu.
Orphazyme's newly appointed CEO is of a different build than his predecessor, Kim Stratton, as his management style is more transparent and inclusive, according to Vice Chairman Bo Jesper Hansen, who is excited that the new top exec is moving to Denmark and already learning the language.
Another deal has fallen into place between Boehringer Ingelheim and the Danish biotech and contract research firm Gubra. The parties have entered into lucrative deals in the past, but will not disclose the financial terms underlying the new agreement.